Evaluation of Local and Systemic Levels of Interleukin-17, Interleukin-23, and Myeloperoxidase in Response to Periodontal Therapy in Patients with Generalized Aggressive Periodontitis

详细信息    查看全文

• 作者：E. Cifcibasi ; C. Koyuncuoglu ; M. Ciblak ; S. Badur ; K. Kasali ; E. Firatli…
• 关键词：aggressive periodontitis ; IL ; 17 ; IL ; 23 ; myeloperoxidase ; periodontal therapy ; gingival crevicular fluid ; serum
• 刊名：Inflammation
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：38
• 期：5
• 页码：1959-1968
• 全文大小：514 KB
• 参考文献：1.Lindhe, J., N.P. Lang, and K. Karring. 2003. Periodontology and implant dentistry, 4th ed, 217. Oxford: Blackwell Munksgaard.
  2.Page, R.C., and K.S. Kornman. 1997. The pathogenesis of human periodontitis: an introduction. Periodontology 2000(14): 9-1.CrossRef
  3.Sahingur, S.E., and R.E. Cohen. 2004. Analysis of host responses and risk for disease progression. Periodontology 2000(34): 57-83. Review.CrossRef
  4.Page, R.C., S. Offenbacher, H.E. Schroeder, G.J. Seymour, and K.S. Kornman. 1997. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontology 2000(14): 216-48.CrossRef
  5.Mosmann, T., H. Cherwinski, M. Bond, M. Giedlin, and R. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136: 2348-357.
  6.Houri-Haddad, Y., A. Wilensky, and L. Shapira. 2007. T-cell phenotype as a risk factor for periodontal disease. Periodontology 2000(45): 67-5.CrossRef
  7.Harrington, L.E., P.R. Mangan, and C.T. Weaver. 2006. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Current Opinion in Immunology 18: 349-56.CrossRef PubMed
  8.Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nature Medicine 13: 139-45. Review.CrossRef PubMed
  9.Tesmer, L.A., S.K. Lundy, S. Sarkar, and D.A. Fox. 2008. Th17 cells in human disease. Immunological Reviews 223: 87-13. doi:10.-111/?j.-600-065X.-008.-0628.?x .PubMed Central CrossRef PubMed
  10.Ferretti, S., O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. The Journal of Immunology 170: 2106-112.CrossRef PubMed
  11.Kramer, J.M., and S.L. Gaffen. 2007. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. Journal of Periodontology 78: 1083-093.CrossRef PubMed
  12.Johnson, R.B., N. Wood, and F.G. Serio. 2004. Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. Journal of Periodontology 75: 37-3.CrossRef PubMed
  13.Eskan, M.A., R. Jotwani, T. Abe, J. Chmelar, J.H. Lim, S. Liang, P.A. Ciero, J.L. Krauss, F. Li, M. Rauner, L.C. Hofbauer, E.Y. Choi, K.J. Chung, A. Hashim, M.A. Curtis, T. Chavakis, and G. Hajishengallis. 2012. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunology 13: 465-73. doi:10.-038/?ni.-260 .PubMed Central CrossRef PubMed
  14.Ito, H., T. Honda, H. Domon, T. Oda, T. Okui, R. Amanuma, T. Nakajima, and K. Yamazaki. 2005. Gene expression analysis of the CD4+ T-cell clones derived from gingival tissues of periodontitis patients. Oral Microbiology and Immunology 20: 382-86.CrossRef PubMed
  15.Vernal, R., N. Dutzan, A. Chaparro, J. Puente, M. Antonieta Valenzuela, and J. Gamonal. 2005. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from persons with chronic periodontitis. Journal of Clinical Periodontology 32: 383-89.CrossRef PubMed
  16.Schenkein, H.A., T.E. Koertge, C.N. Brooks, R. Sabatini, D.E. Purkall, and J.G. Tew. 2010. IL-17 in sera from patients with aggressive periodontitis. Journal of Dental Research 89: 943. doi:10.-177/-022034510369297-/span> .PubMed Central CrossRef PubMed
  17.Ozcaka, O., A. Nalbantsoy, and N. Buduneli. 2011. Interleukin-17 and interleukin-18 levels in saliva and plasma of patients with chronic periodontitis. Journal of Periodontal Research 46: 592-98.PubMed
  18.Lester, S.R., J.L. Bain, R.B. Johnson, and F.G. Serio. 2007. Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. Journal of Periodontology 78: 1545-550.CrossRef PubMed
  19.Zhao, L., Y. Zhou, Y. Xu, Y. Sun, L. Li, and W. Chen. 2011. Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients. Journal of Clinical Periodontology 38: 509-16.CrossRef PubMed
  20.Duarte, P.M., M. da Rocha, E. Sampaio, M.J. Mestnik, M. Feres, L.C. Figueiredo, M.F. Bastos, and M. Faveri. 2010. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. Journal of Periodontology 81: 1056-063.CrossRef PubMed
  21.Borch, T.S., M. Lobner, K. Bendtzen, P. Holmstrup, and C.H. Nielsen. 2009. Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. Journal of Periodontology 80: 800-87.CrossRef PubMed
  22.Takahashi, K., T. Azuma, H. Motohira, D.F. Kinane, and S. Kitetsu. 2005. The potential role of interleukin-17 in the immunopathology of peri
• 作者单位：E. Cifcibasi (1)
  C. Koyuncuoglu (2)
  M. Ciblak (3)
  S. Badur (3)
  K. Kasali (4)
  E. Firatli (1)
  S. Cintan (1)
  
  1. Department of Periodontology, Faculty of Dentistry, Istanbul University, Capa, 34093, Istanbul, Turkey
  2. Department of Periodontology, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey
  3. Division of Virology and Immunology, Department of Microbiology, Istanbul Medical School, Istanbul University, Istanbul, Turkey
  4. Department of Biostatistics, Istanbul Medical School, Istanbul University, Istanbul, Turkey
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Rheumatology
  Internal Medicine
  Pharmacology and Toxicology
  Pathology
  
• 出版者：Springer Netherlands
• ISSN：1573-2576

文摘

We aimed to investigate serum and gingival crevicular fluid levels of myeloperoxidase, interleukin-17, and interleukin-23 before and after nonsurgical periodontal therapy in generalized aggressive periodontitis patients and compare to those in healthy controls. Interleukin-17, interleukin-23, and myeloperoxidase levels were measured by enzyme-linked immunosorbent assay in gingival crevicular fluid and serum samples taken from 19 systemically healthy generalized aggressive periodontitis patients and 22 healthy controls. In addition, the levels of IL-17, IL-23, and myeloperoxidase were reassessed at 3 months after periodontal therapy in the generalized aggressive periodontitis (GAP) group. Periodontal clinical parameters were also evaluated at baseline and 3 months post-therapy. The investigated molecule levels in serum decreased significantly at 3 months as a result of the therapy (p--.014 for IL-17, p--.000 for IL-23, and p--.001 for myeloperoxidase (MPO)). Significant reductions were also observed in gingival crevicular fluid (GCF) IL-17, IL-23, and MPO levels at 3 months after therapy (p--.000 for all molecules). However, the GCF levels of IL-17, IL-23, and MPO in GAP patients were still higher than those in the controls at 3 months (p--.001). A significant decrease in the local and systemic levels of IL-17, IL-23, and MPO based on the therapy might indicate the role of these mediators for tissue destruction in periodontal tissues. KEY WORDS aggressive periodontitis IL-17 IL-23 myeloperoxidase periodontal therapy gingival crevicular fluid serum